The Annual General Meeting on 17th May, 2021 resolved on the proposal of the Board of Directors to authorize the Board of Directors to, in one or more transactions, decide on the issuance of shares as well as the issuance of options and other special rights entitling to shares referred to in chapter 10 section 1 of the Companies Act as follows:
The number of shares to be issued based on the authorization may in total amount to a maximum of 6,850,000 shares, corresponding to approximately 10 % of all the shares in the Company.
The Board of Directors decides on all the terms and conditions of the issuances of shares, options and other special rights entitling to shares. The authorization concerns both the issuance of new shares as well as the transfer of treasury shares. The issuance of shares, options and other special rights entitling to shares may be carried out in deviation from the shareholders’ pre-emptive rights (directed issue).
The authorization cancels the authorization given by the Annual General Meeting on 24 April 2020 to decide on the issuance of shares and special rights entitling to shares and the authorizations given by the Extraordinary General Meeting on 9 March 2021 to decide on a rights issue and a directed issuance of shares.
The authorization is in force until the end of the next Annual General Meeting, however no longer than until 30 June 2022.
The Extraordinary General Meeting on 9th March, 2021 resolved in accordance with the proposal of the Board of Directors to authorise the Board of Directors to decide on a directed share issue based on which a maximum of 35 000 000 new shares may be issued. The shares will be offered in deviation from the Company’s shareholder’ pre-emptive subscription right to be subscribed for by Inission AB (publ) (“Inission”) and Joensuun Kauppa ja Kone Oy at a subscription price of EUR 0.2 per share. The authorisation for the directed share issue is valid until 31 December 2021. The authorisation does not revoke any prior authorisations granted to the Board of Directors.
The Annual General Meeting on 24th April, 2020 resolved on the proposal of the Board of Directors to authorize the Board of Directors to, in one or more transactions, decide on the issuance of shares and the issuance of options and other special rights entitling to shares referred to in chapter 10 section 1 of the Companies Act as follows:
The number of shares to be issued based on the authorization may in total amount to a maximum of 1,686,500 shares, corresponding to approximately 20 % of all the shares in the company.
The Board of Directors decides on all the terms and conditions of the issuances of shares, options and other special rights entitling to shares. The authorization concerns both the issuance of new shares as well as the transfer of treasury shares. The issuance of shares and special rights entitling to shares may be carried out in deviation from the shareholders’ pre-emptive rights (directed issue).
The authorization cancels the authorization given by the Annual General Meeting on 11 April 2019 to decide on the issuance of shares and special rights entitling to shares.
The authorization is valid until the close of the following Annual General Meeting.
The Annual General Meeting on April 11, 2019 resolved on the proposal of the Board of Directors to authorize the Board of Directors to, in one or more transactions, decide on the issuance of shares and the issuance of options and other special rights entitling to shares referred to in chapter 10 section 1 of the Companies Act as follows:
The number of shares to be issued based on the authorization may in total amount to a maximum of 84,320,000 shares, corresponding to approximately 20.0 % of all the shares in the company.
The Board of Directors decides on all the terms and conditions of the issuances of shares, options and other special rights entitling to shares. The authorization concerns both the issuance of new shares as well as the transfer of treasury shares. The issuance of shares and special rights entitling to shares may be carried out in deviation from the shareholders’ pre-emptive rights (directed issue).
The authorization cancels the authorization given by the Annual General Meeting on 12 April 2018 to decide on the issuance of shares and special rights entitling to shares.
The authorization is valid until the close of the following Annual General Meeting, however, no longer than until 30 June 2020.
The Annual General Meeting on April 12, 2018 resolved on the proposal of the Board of Directors to authorize the Board of Directors to, in one or more transactions, decide on the issuance of shares and the issuance of options and other special rights entitling to shares referred to in chapter 10 section 1 of the Companies Act as follows:
The number of shares to be issued based on the authorization may in total amount to a maximum of 11,150,000 shares, corresponding to approximately 20.0 % of all the shares in the company.
The Board of Directors decides on all the terms and conditions of the issuances of shares, options and other special rights entitling to shares. The authorization concerns both the issuance of new shares as well as the transfer of treasury shares. The issuance of shares and special rights entitling to shares may be carried out in deviation from the shareholders’ pre-emptive rights (directed issue).
The authorization cancels the authorization given by the Annual General Meeting on 5 April 2017 to decide on the issuance of shares and special rights entitling to shares.
The authorization is valid until the close of the following Annual General Meeting, however, no longer than until 30 June 2019.
The Extraordinary General Meeting on May 3, 2018 resolved on the proposal of the Board of Directors to authorise the Board of Directors to decide on a share issue according to the pre-emption rights of shareholders.
The authorisation entitles the Board to issue a maximum of 390,410,237 shares. The share issue may be implemented by issuing new shares or transferring shares now in possession of the company. The Board can use the authorisation in one or more parts. The Board of directors was authorised to decide on any other conditions of the issuance of shares.
The authorisation is valid until 31 December 2018. The authorisation does not revoke any prior authorisations granted to the Board of Directors.